Clinical Trial Update: Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Umbilical Cord Blood NK cells with Rituximab, high-dose chemotherapy, and stem cell transplant in recurrent or refractory B-cell non-Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Indolent Adult Non-hodgkin Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)
• Umbilical Cord Blood NK Cells

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Mantle Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2023-02-16